Abstract | BACKGROUND: This study sought to define the mechanism by which PPAR-γ ligands affect the course of experimentally induced colitis in rats. MATERIAL/METHODS: RESULTS: Rats receiving rosiglitazone had higher body weight, whereas large intestine weight/length ratio was lower; histology showed fewer inflammatory markers. Rats receiving TNBS and TNBS along with BADGE had more intensive inflammatory changes. Rosiglitazone alone decreased expression of IL-6; used with TNBS it decreased expression of MPO in intestinal tissue, yet did not increase the expression of IL-10. Decreased levels of MPO indicate reduced neutrophil-dependent immune response. The antagonist of PPAR-γ increased IL-6 in serum and decreased IL-10 in intestinal homogenates. Bisphenol A diglycidyl ether administrated to healthy animals increases serum IL-6 levels. CONCLUSIONS:
|
Authors | Krzysztof Celinski, Tomasz Dworzanski, Agnieszka Korolczuk, Maria Slomka, Sebastian Radej, Halina Cichoz-Lach, Agnieszka Madro |
Journal | Medical science monitor : international medical journal of experimental and clinical research
(Med Sci Monit)
Vol. 17
Issue 4
Pg. BR116-24
(Apr 2011)
ISSN: 1643-3750 [Electronic] United States |
PMID | 21455100
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Interleukin-6
- PPAR gamma
- Tissue Extracts
- Interleukin-10
- Peroxidase
|
Topics |
- Animals
- Body Weight
- Colitis
(blood, chemically induced, metabolism, pathology)
- Colon
(metabolism, pathology)
- Interleukin-10
(blood)
- Interleukin-6
(blood)
- Organ Size
- PPAR gamma
(metabolism)
- Peroxidase
(blood)
- Rats
- Rats, Wistar
- Tissue Extracts
|